I believe what has occurred is this:
Originally company was international pharmacy;
that company was sold, name changed to Bionic Products with
symbol BNPD.PK;
Bionic Products had 2 beverages to sell- bionic tonic
and lady pink. The company sold tons of shares, and on March 1, 2010, the company issued an unannounced 1:5,000 rs. That wiped out most investors, and should have left shares outstanding to 500,000.
The new deal is VAGUE as to whether Biocen Natural is a subsidiary of the former Bionic Products the beverage comapny, or if the shell company was simply sold to Biocen Natural. I recall reading that NO CASH CHANGED HANDS.
It's curious that from March 1, 2010 to the time of the new deal with Biocen Natural, the shares outstanding ballooned to over 120,000,000 (from 500,000 after the rs), with another 120,000,000 being issued to buy BEHL.
I have no understanding of WHAT HAPPENED TO BIONIC PRODUCTS the beverage company's inventory, nor if its investors were compensated by BIOCEN NATURAL for the right to use the printing press to print and sell more BNPD stock.
Nor, how the management of Bionic Products the beverage company, can claim it is now private, while investors before the deal had ownership in the products, licensing agreements, etcs.
I have hunch name BIOCEN NATURAL PRODUCT DEVELOPMENT was selected to keep symbol BNPD.
How did BIOCEN NATURAL get the legal right to simply start printing stock under the symbol BNPD: did they pay anything for that right? Are they a subsidiary of the original Bionic Products the beverage company?
What has occurred now is BNPD as Biocen Natural has spent money
(in the form of 120,000,000 shares of BNPD) in buying BEHL;
is spending money to create and market its algae products;
and has incurred a $5 million dollar loan to push the BEHL product line, and the algae beverages.
It's curious whether the new Biocen Natural management understands the importance of working with investors, and has the knowledge of how to help BOTH BEHL and the algae beverages succeed. Spending money is one thing, and getting sales is another.
At least, the management of Biocen Natural seems to take an interest in setting short term goals, funding them sensibly, and keeping its promises for deadlines for results.
